Annual ROE
-38.09%
-4.56%-13.60%
December 31, 2024
Summary
- As of March 12, 2025, VIR annual return on equity is -38.09%, with the most recent change of -4.56% (-13.60%) on December 31, 2024.
- During the last 3 years, VIR annual ROE has fallen by -87.29% (-177.42%).
- VIR annual ROE is now -137.58% below its all-time high of 101.36%, reached on December 31, 2017.
Performance
VIR ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-37.48%
-1.86%-5.22%
December 31, 2024
Summary
- As of March 12, 2025, VIR quarterly return on equity is -37.48%, with the most recent change of -1.86% (-5.22%) on December 31, 2024.
- Over the past year, VIR quarterly ROE has dropped by -7.50% (-25.02%).
- VIR quarterly ROE is now -105.32% below its all-time high of 703.88%, reached on September 30, 2019.
Performance
VIR Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
VIR ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -13.6% | -25.0% |
3 y3 years | -177.4% | -429.4% |
5 y5 years | +73.3% | -429.4% |
VIR ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -177.4% | at low | -135.1% | at low |
5 y | 5-year | -177.4% | +73.3% | -135.1% | +80.4% |
alltime | all time | -137.6% | +73.3% | -105.3% | +80.4% |
Vir Biotechnology ROE History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -38.09%(+13.6%) | -37.48%(+5.2%) |
Sep 2024 | - | -35.62%(+18.8%) |
Jun 2024 | - | -29.98%(-4.5%) |
Mar 2024 | - | -31.39%(-6.9%) |
Dec 2023 | -33.53%(-214.1%) | -33.70%(+8.7%) |
Sep 2023 | - | -31.01%(+135.8%) |
Jun 2023 | - | -13.15%(+85.7%) |
Mar 2023 | - | -7.08%(-126.4%) |
Dec 2022 | 29.39%(-40.3%) | 26.83%(-60.5%) |
Sep 2022 | - | 67.93%(-11.8%) |
Jun 2022 | - | 77.00%(-27.9%) |
Mar 2022 | - | 106.73%(+78.2%) |
Dec 2021 | 49.20% | 59.89%(-544.0%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2021 | - | -13.49%(-68.4%) |
Jun 2021 | - | -42.71%(-31.6%) |
Mar 2021 | - | -62.47%(+21.2%) |
Dec 2020 | -52.36%(-63.3%) | -51.54%(-23.7%) |
Sep 2020 | - | -67.59%(-8.7%) |
Jun 2020 | - | -74.05%(-50.5%) |
Mar 2020 | - | -149.68%(-21.7%) |
Dec 2019 | -142.74%(-320.7%) | -191.21%(-127.2%) |
Sep 2019 | - | 703.88%(-738.8%) |
Jun 2019 | - | -110.18%(-323.0%) |
Mar 2019 | - | 49.40%(+47.9%) |
Dec 2018 | 64.68%(-36.2%) | 33.40% |
Dec 2017 | 101.36% | - |
FAQ
- What is Vir Biotechnology annual return on equity?
- What is the all time high annual ROE for Vir Biotechnology?
- What is Vir Biotechnology annual ROE year-on-year change?
- What is Vir Biotechnology quarterly return on equity?
- What is the all time high quarterly ROE for Vir Biotechnology?
- What is Vir Biotechnology quarterly ROE year-on-year change?
What is Vir Biotechnology annual return on equity?
The current annual ROE of VIR is -38.09%
What is the all time high annual ROE for Vir Biotechnology?
Vir Biotechnology all-time high annual return on equity is 101.36%
What is Vir Biotechnology annual ROE year-on-year change?
Over the past year, VIR annual return on equity has changed by -4.56% (-13.60%)
What is Vir Biotechnology quarterly return on equity?
The current quarterly ROE of VIR is -37.48%
What is the all time high quarterly ROE for Vir Biotechnology?
Vir Biotechnology all-time high quarterly return on equity is 703.88%
What is Vir Biotechnology quarterly ROE year-on-year change?
Over the past year, VIR quarterly return on equity has changed by -7.50% (-25.02%)